Sms Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 1987.
1987 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Sms Pharmaceuticals Limited

Sms Pharmaceuticals Limited, a active public limited company, was established on 14 December 1987 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24239TG1987PLC008066. Registered under ROC Roc Hyderabad. it is listed on BSE: 532815 and NSE: SMSPHARMA. It has an authorized capital of ₹12.00 Cr and a paid-up capital of ₹9.37 Cr.

Formerly known as S.M.S. Pharmaceuticals Private Limited, Sms Pharmaceuticals Pvt Limited. It upholds a compliant status. In 2024, it reported revenue of ₹713.72 Cr and a net worth of ₹570.49 Cr. Employing 1,193 professional, Its leadership includes Srinivas Sarvepalli (Director), Vamsi Krishna Potluri (Whole-Time Director), Shravan Kudaravalli (Director). Past directors included Srinivas Sarvepalli, Uma Maheswaram Kuravi, Shilpa R Waghmare. It holds ₹600.28 Cr open charges and ₹640.70 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 72, H.No: 8-2-334/3&4, Road No. 5 Opp. Sbi Executive Enclave, Banjara Hill, S, Hyderabad, Telangana, 500034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24239TG1987PLC008066

  • Registration Number

    008066

  • Incorporation Date

    14 December 1987

  • Authorized Capital

    ₹12.00 Cr

  • Paid-Up Capital

    ₹9.37 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Listed (BSE: 532815, NSE: SMSPHARMA)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 12.00 Cr
  • Paid Up Capital ₹ 9.37 Cr
  • Company Age 38 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 600.28 Cr
  • Satisfied Charges ₹ 640.70 Cr
  • Revenue Growth **** 35.45%
  • Profit Growth **** 1110.03%
  • Ebitda **** 4.31%
  • Net Worth 15.23%
  • Total Assets **** 16.85%
Company report

Sms Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sms Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sms Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Srinivas Sarvepalli Director 12 Aug 2019 Current
Vamsi Krishna Potluri Whole-Time Director 05 Jun 2020 Current
Shravan Kudaravalli Director 26 May 2018 Current
Ramesh Babu Potluri Managing Director 01 Dec 2008 Current
Trilok Potluri Director 12 Aug 2024 Current
Shanti Sree Bolleni Director 12 Aug 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Nominee Director 18 Apr 2012 Past
Pramod Abcsdd Nominee Director 08 Aug 2022 Past
Pramod Abcsdd Nominee Director 31 Jan 2019 Past
Pramod Abcsdd Director 09 Oct 2015 Past
Pramod Abcsdd Additional Director 30 Sep 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sms Pharmaceuticals.

Sms Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 35.45% increase. The company also saw a substantial improvement in profitability, with a 1110.03% increase in profit. The company's net worth Soared by an impressive increase of 15.23%.

Sms Pharmaceuticals revenue growth over time
Sms Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 35.45%
*******
*******
*******
*******
Revenue from Operations
*******
 35.86%
*******
*******
*******
*******
Total Assets
*******
 16.85%
*******
*******
*******
*******
Profit or Loss
*******
 1110.03%
*******
*******
*******
*******
Net Worth
*******
 15.23%
*******
*******
*******
*******
EBITDA
*******
 4.31%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sms Pharmaceuticals?

In 2024, Sms Pharmaceuticals had a promoter holding of 64.67% and a public holding of 35.32%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹6,002,820,000.00

Satisfied Charges

₹6,407,039,680.00

Charges Breakdown by Lending Institutions
  • Others : 232.39 Cr
  • State Bank Of India : 197.03 Cr
  • Idbi Bank Limited : 136.70 Cr
  • Axis Bank Limited : 34.15 Cr
  • Mid - West Leasing Ltd. : 0.01 Cr
Latest Charge Details
Date Lender Amount Status
22 Oct 2025 Axis Bank Limited ₹34.15 Cr Open
14 Feb 2024 Others ₹100.00 Cr Open
24 Jan 2023 Idbi Bank Limited ₹25.00 Cr Open
08 Mar 2022 Others ₹16.09 Cr Open
25 Feb 2022 State Bank Of India ₹23.20 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Sms Pharmaceuticals?

Sms Pharmaceuticals has a workforce of 1193 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sms Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sms Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sms Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge with Others of Rs. 40.00 Cr registered on 24 Jun 2016 with Charge ID 100035079 was modified on 11 Nov 2025. was recorded as a recent event.

  • Charges

    The activity A charge with State Bank Of India of Rs. 173.83 Cr registered on 11 May 1989 with Charge ID 90260758 was modified on 11 Nov 2025. was completed.

  • Charges

    The activity A charge registered on 02 Nov 2023 via Charge ID 100819428 with Others was fully satisfied on 28 Oct 2025. was completed.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 34.15 Cr with Charge ID 101182903 was registered on 22 Oct 2025. was recorded as a recent event.

  • Annual General Meeting

    Sms Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Sms Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sms Pharmaceuticals Limited?

The CIN of Sms Pharmaceuticals Limited is L24239TG1987PLC008066.

Where is Sms Pharmaceuticals Limited headquartered?

Sms Pharmaceuticals Limited is headquartered at Plot No. 72, H.No: 8-2-334/3&4, Road No. 5 Opp. Sbi Executive Enclave, Banjara Hill, S, Hyderabad, Telangana, 500034.

When was Sms Pharmaceuticals Limited incorporated?

Sms Pharmaceuticals Limited was incorporated on 14 December 1987.

Who are the current directors of Sms Pharmaceuticals Limited?

The current directors of Sms Pharmaceuticals Limited are

What is the primary industry of Sms Pharmaceuticals Limited?

The primary industry of Sms Pharmaceuticals Limited is Manufacturing.

Is Sms Pharmaceuticals Limited a listed company?

Sms Pharmaceuticals Limited is listed. It is listed on BSE: 532815 and NSE: SMSPHARMA.

What is the capital structure of Sms Pharmaceuticals Limited?

The authorized capital of Sms Pharmaceuticals Limited is ₹12.00 Cr, and the paid-up capital is ₹9.37 Cr.

What is the compliance status of Sms Pharmaceuticals Limited?

The compliance status of Sms Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available